dijous, 16 d’octubre del 2014

FDA approves Bracco's Lumason imaging agent




The FDA approves Bracco Diagnostics' Lumason imaging agent for hard-to-see cardiac ultrasounds.






The FDA approved Bracco Diagnostics' Lumason agent for patients whose ultrasound image of the heart are hard to see with ultrasound waves.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/11uBH2a

Cap comentari:

Publica un comentari a l'entrada